IRM Q1 2026 Earnings Strong EPS Beat Highlights Resilient REIT Performance Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amidst Flat Stock Reaction CIB Q4 2025 Earnings Massive EPS Miss as Company Reports Deep Loss QVCGP Q3 2025 Earnings Significant Loss Per Common Share Reported Preferred Stock Unchanged TRDA Q1 2026 Earnings SmallerThanExpected Loss Offers Cautious Optimism Amid PreRevenue Stage Bakkt Q1 2026 Earnings Significant EPS Miss Amid Ongoing Operational Challenges